WC
WVE icon

Wexford Capital’s Wave Life Sciences WVE Stock Holding History

Wexford Capital’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-77,240
Closed -$1.59M – 160
2019
Q3 		$1.59M Hold
77,240
– – 0.22% 64
2019
Q2 		$2.02M Buy
77,240
+20,000
+35% +$561K 0.23% 65
2019
Q1 		$2.22M Buy
57,240
+47,000
+459% +$1.91M 0.18% 49
2018
Q4 		$430K Buy
+10,240
New +$455K 0.04% 68
2018
Q2 		– Sell
-20,000
Closed -$802K – 152
2018
Q1 		$802K Hold
20,000
– – 0.06% 77
2017
Q4 		$702K Sell
20,000
-5,000
-20% -$146K 0.06% 97
2017
Q3 		$544K Hold
25,000
– – 0.05% 112
2017
Q2 		$465K Buy
+25,000
New +$539K 0.03% 114

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wexford Capital's WVE Position: Q4 2019 in Review

Wexford Capital sold out of Wave Life Sciences (WVE) in Q4 2019, closing a stake of 77,240 shares — an estimated $1.59M sold.

Wexford Capital first reported a position in WVE in Q2 2017 and held it in 8 quarters. The position peaked at $2.22M in Q1 2019. 90 funds tracked by Wall St. Rank hold WVE as of Q4 2019.

  • Wexford Capital reported no remaining Wave Life Sciences position as of Q4 2019 after selling out during the quarter.
  • Wexford Capital sold 77,240 Wave Life Sciences shares in Q4 2019, an estimated $1.59M.
  • Wexford Capital first reported a position in Wave Life Sciences in Q2 2017 and held it in 8 quarters.
  • Wexford Capital's Wave Life Sciences position peaked at $2.22M in Q1 2019.
  • 90 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2019.

Based on Wexford Capital's 13F filing for Q4 2019, filed 14 Feb 2020.